Vivifi Device Safety Evaluation for the Treatment of Benign Prostatic Hyperplasia
The study objective is to evaluate the safety and feasibility of the Vivifi device to treat symptomatic, benign prostatic hyperplasia (BPH).
Male 45-80 years of age [+6]
Patients with prior history of relevant scrotal or testicular vascular surgeries... [+13]